The Hormone Metabolism and Methylation DNA Panel examines genes that regulate how the body produces, metabolizes, and eliminates sex hormones (estrogen, progesterone, testosterone) as well as genes involved in DNA methylation, which influences gene expression.

This testing can provide insights for people with hormone-related conditions like PCOS, endometriosis, estrogen dominance, or those starting hormone replacement therapy, by showing how efficiently their body processes and clears hormones. It can also be useful for women with painful cycles or a family history of hormone-sensitive cancers, as well as individuals with chronic fatigue, mood disorders, brain fog, or sleep issues resistant to conventional care.

Additionally, it identifies methylation-related gene variants (such as MTHFR, COMT, and BHMT), which may impact cardiovascular, neurological, and detox pathways. Beyond medical concerns, health optimizers and longevity seekers also use this panel to better tailor lifestyle and treatment strategies.